| Identification | Back Directory | [Name]
tert-butyl-[2-hydroxy-3-[2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]propyl]azanium chloride | [CAS]
152289-59-3 | [Synonyms]
Proxodolol hydrochloride
tert-butyl-[2-hydroxy-3-[2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]propyl]azanium chloride
2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]-, monohydrochloride | [Molecular Formula]
C17H26ClN3O4 | [MOL File]
152289-59-3.mol | [Molecular Weight]
371.859 |
| Hazard Information | Back Directory | [Description]
Proxodolol is a β-adrenergic receptor antagonist potentially for the treatment of glaucoma, hypertension and angina. | [Uses]
Proxodolol is a β-adrenergic receptor blocker. Proxodolol can be used for the study of arterial hypertension[1]. | [References]
[1] S A Beliaeva. Efficacy and safety of the first made in Russia αβ long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree. Ter Arkh. 2011;83(4):52-5. PMID:21675275 |
|
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|